Skip to main content

Table 1 Tumor characteristics and descriptive data of the 24 study subjects

From: No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression

Subject Age (years) CTC before CTC after Maximum tumor pressure (kPa) Tumor size (mm) Nodal status Histology Histologic grade Multifocal Vascular invasion ER PR HER2 Ki-67 (%)
1 (a) 66 0 0 13 21 IDC 3 + + + 50
2 (a) 70 0 0 7 13 IDC 3 70
3 (s) 85 0 0 9 NA NA Non-Hodgkin’s lymphoma NA NA NA NA NA NA NA
4 (a) 65 1 1 10 30 IDC 2 + + 15
5 (a) 51 0 0 11 19 Medullary carcinoma 3 80
6 (a) 51 0 0 10 12 IDC 2 + + 25
7 (s) 83 0 0 4 17 Intracystic papillary carcinoma 2 NA + + NA
8 (a) 58 1 0 7 13 IDC 1 + 14
9 (a) 61 0 0 1 11 IDC 3 + + 30
10 (s) 85 0 0 14 22 + IDC 3 + + 75
11 (a) 64 0 0 4 9 Metaplastic carcinoma 3 + 30
12 (s) 87 0 0 12 19 IDC 2 + + + 17
13 (s) 78 0 0 11 25 IDC 3 + 35
14 (s) 77 1 0 3 NA NA Benign cyst NA NA NA NA NA NA NA
15 (a) 63 0 0 20 20 + IDC 1 + + + 15
16 (s) 83 0 0 2 19 IDC 2 + + 21
17 (s) 67 0 0 6 22 + ILC 2 + + 5
18 (s) 58 0 0 36 12 + IDC 1 + 10
19 (a) 63 0 0 24 15 IDC 2 + 45
20 (s) 81 2 1 4 25 + ILC 3 + 24
21 (a) 70 0 0 17 10 + ILC 1 + + + 13
22 (s) 63 0 0 3 25 IDC 3 80
23 (a) 72 0 0 6 17 IDC 3 + + 25
24 (a) 66 0 0 NA 30 + Apokrine carcinoma 2 21
  1. a Asymptomatic, s symptomatic, NA not applicable, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma